Drug class · Endocrine & metabolism

GLP-1 receptor agonists Drug Codes & NDCs

Drugs that activate the glucagon-like peptide-1 (GLP-1) receptor. The class includes injectable and oral products; tirzepatide is also listed here because it acts on both the GLP-1 and GIP receptors.

121 finished products listed with the FDA

FDA-listed products

Finished products in the GLP-1 receptor agonists class, A–Z by brand
ProductStrengthForm · routeLabelerProduct NDC
Mounjaro KwikPentirzepatideTirzepatide 20.8 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3422
Mounjaro KwikPentirzepatideTirzepatide 16.7 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3433
Mounjaro KwikPentirzepatideTirzepatide 12.5 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3444
Mounjaro KwikPentirzepatideTirzepatide 8.33 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3455
Mounjaro KwikPentirzepatideTirzepatide 4.17 mg/mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3466
Ozempicoral semaglutideSemaglutide 4 mg/1TabletOralNovo Nordisk Pharmaceutical Industries, LP0169-1704
Ozempicoral semaglutideSemaglutide 9 mg/1TabletOralNovo Nordisk Pharmaceutical Industries, LP0169-1709
Ozempicoral semaglutideSemaglutide 1.5 mg/1TabletOralNovo Nordisk Pharmaceutical Industries, LP0169-1715
OzempicsemaglutideSemaglutide 1.34 mg/mLInjection, SolutionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-4130
OzempicsemaglutideSemaglutide .68 mg/mLInjection, SolutionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-4181
OzempicsemaglutideSemaglutide 2.68 mg/mLInjection, SolutionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-4772
OzempicsemaglutideSemaglutide 1.34 mg/mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-5949
OzempicsemaglutideSemaglutide 2.68 mg/mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-6051
OzempicsemaglutideSemaglutide .68 mg/mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-8027
Rybelsusoral semaglutideSemaglutide 3 mg/1TabletOralNovo Nordisk Pharmaceutical Industries, LP0169-4303
Rybelsusoral semaglutideSemaglutide 7 mg/1TabletOralNovo Nordisk Pharmaceutical Industries, LP0169-4307
Rybelsusoral semaglutideSemaglutide 14 mg/1TabletOralNovo Nordisk Pharmaceutical Industries, LP0169-4314
SaxendaliraglutideLiraglutide 6 mg/mLInjection, SolutionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-2800
SaxendaliraglutideLiraglutide 6 mg/mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-4257
Soliqua 100/33insulin glargine and lixisenatideInsulin glargine 100 U/mL; Lixisenatide 33 ug/mLInjection, SolutionSubcutaneousSanofi-Aventis U.S. LLC0024-5761
TrulicitydulaglutideDulaglutide .75 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-1433
TrulicitydulaglutideDulaglutide 1.5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-1434
TrulicitydulaglutideDulaglutide 3 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-2236
TrulicitydulaglutideDulaglutide 4.5 mg/.5mLInjection, SolutionSubcutaneousEli Lilly and Company0002-3182
TrulicitydulaglutideDulaglutide 1.5 mg/.5mLInjection, SolutionSubcutaneousA-S Medication Solutions50090-3483

Med-Code uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in